Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered Through Systematic Combination Screening

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0925

Related search